Peptides to Public Health: Pharma-Biotech Sector to Open 90 New Facilities in 2014 with Potential $4 Billion Investment
Peptides to Public Health: Pharma-Biotech Sector to Open 90 New Facilities in 2014 with Potential $4 Billion Investment
SUGAR LAND--March 12, 2014--Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas)--Before 2014 draws to a close, the Pharmaceutical-Biotech Industry is forecast to open the doors of 90 new plants and research centers across North America. A recent survey of reported projects in Industrial Info's Pharmaceutical Tracker - Online Database reveals that cumulatively, the projects represent a potential total investment value (TIV) of $3.9 billion, which includes both original construction costs and possible future phases that already are planned or under consideration. The projects reported include grassroot facilities, building additions, and the repurposing of existing sites.
Other companies featured: BioMed Realty Trust (NYSE:BMR), Vertex Pharmaceuticals (NASDAQ:VRTX)
Subscribe Now!(All Fields Required)
Related Articles
Articles related to this company
- North American Pharma-Biotech Sector to Wrap up Construction on 157 Project...
- Suffolk Construction Has Hand in $1.9 Billion Worth of Projects
- Turner Construction Involved in More than $24 Billion Worth of U.S. Project...
- Suffolk Construction Has Hand in $1.8 Billion Worth of U.S. Projects, Mostl...
- New England Sees $23.3 Billion in Projects Under Construction